TrialVascular pharmacology2023

Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease.

Nishank Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.